Denmark's Novo A/S ups Synlab stake to 20 pct before possible IPO: Reuters

Danish life science investor Novo A/S said on Wednesday it was raising its stake in Synlab to about 20 percent through a 250 million euro ($265 million) subscription to new shares, ahead of a potential listing of Europe's second largest lab operator.

DealsNorth AmericaUSBriefs